Guggenheim Capital’s Ingevity NGVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-5,903
| Closed | -$254K | – | 1635 |
|
|
2025
Q2 | $254K | Sell |
5,903
-126
| -2% | -$4.86K | ﹤0.01% | 1441 |
|
|
2025
Q1 | $239K | Sell |
6,029
-1,054
| -15% | -$46.6K | ﹤0.01% | 1487 |
|
|
2024
Q4 | $289K | Sell |
7,083
-813
| -10% | -$33.9K | ﹤0.01% | 1466 |
|
|
2024
Q3 | $308K | Sell |
7,896
-1,826
| -19% | -$72.7K | ﹤0.01% | 1601 |
|
|
2024
Q2 | $425K | Buy |
9,722
+1,264
| +15% | +$61.1K | ﹤0.01% | 1506 |
|
|
2024
Q1 | $403K | Sell |
8,458
-968
| -10% | -$43.5K | ﹤0.01% | 1560 |
|
|
2023
Q4 | $445K | Buy |
9,426
+477
| +5% | +$19.8K | ﹤0.01% | 1501 |
|
|
2023
Q3 | $426K | Sell |
8,949
-2,438
| -21% | -$133K | ﹤0.01% | 1505 |
|
|
2023
Q2 | $662K | Sell |
11,387
-156
| -1% | -$9.36K | 0.01% | 1339 |
|
|
2023
Q1 | $826K | Sell |
11,543
-8,696
| -43% | -$690K | 0.01% | 1277 |
|
|
2022
Q4 | $1.43M | Sell |
20,239
-1,377
| -6% | -$97.1K | 0.01% | 995 |
|
|
2022
Q3 | $1.31M | Sell |
21,616
-1,304
| -6% | -$87.5K | 0.01% | 1014 |
|
|
2022
Q2 | $1.45M | Buy |
22,920
+3,094
| +16% | +$202K | 0.01% | 1046 |
|
|
2022
Q1 | $1.27M | Buy |
19,826
+6,471
| +48% | +$433K | 0.01% | 1237 |
|
|
2021
Q4 | $958K | Sell |
13,355
-3,873
| -22% | -$295K | 0.01% | 1391 |
|
|
2021
Q3 | $1.23M | Sell |
17,228
-2,471
| -13% | -$195K | 0.01% | 1312 |
|
|
2021
Q2 | $1.6M | Buy |
19,699
+14,703
| +294% | +$1.18M | 0.01% | 1226 |
|
|
2021
Q1 | $377K | Sell |
4,996
-1,056
| -17% | -$76.9K | ﹤0.01% | 1861 |
|
|
2020
Q4 | $458K | Buy |
6,052
+1,199
| +25% | +$78.1K | ﹤0.01% | 1676 |
|
|
2020
Q3 | $240K | Buy |
4,853
+1,034
| +27% | +$58.4K | ﹤0.01% | 1721 |
|
|
2020
Q2 | $201K | Buy |
+3,819
| New | +$181K | ﹤0.01% | 1748 |
|
|
2020
Q1 | – | Sell |
-3,778
| Closed | -$330K | – | 1947 |
|
|
2019
Q4 | $330K | Buy |
3,778
+39
| +1% | +$3.41K | ﹤0.01% | 1782 |
|
|
2019
Q3 | $317K | Sell |
3,739
-870
| -19% | -$77.5K | ﹤0.01% | 1822 |
|
|
2019
Q2 | $485K | Sell |
4,609
-24
| -0.5% | -$2.41K | ﹤0.01% | 1665 |
|
|
2019
Q1 | $489K | Sell |
4,633
-678
| -13% | -$68.1K | ﹤0.01% | 1690 |
|
|
2018
Q4 | $444K | Buy |
5,311
+1,853
| +54% | +$168K | ﹤0.01% | 1732 |
|
|
2018
Q3 | $352K | Buy |
3,458
+810
| +31% | +$78.2K | ﹤0.01% | 2151 |
|
|
2018
Q2 | $214K | Sell |
2,648
-48,537
| -95% | -$3.86M | ﹤0.01% | 2284 |
|
|
2018
Q1 | $3.77M | Sell |
51,185
-604
| -1% | -$45.2K | 0.01% | 1174 |
|
|
2017
Q4 | $3.65M | Buy |
51,789
+12,921
| +33% | +$932K | 0.01% | 1219 |
|
|
2017
Q3 | $2.43M | Buy |
38,868
+632
| +2% | +$37.4K | 0.01% | 1519 |
|
|
2017
Q2 | $2.19M | Sell |
38,236
-763
| -2% | -$44.9K | 0.01% | 1563 |
|
|
2017
Q1 | $2.38M | Buy |
38,999
+8,071
| +26% | +$457K | 0.01% | 1533 |
|
|
2016
Q4 | $1.7M | Sell |
30,928
-22,306
| -42% | -$1.07M | ﹤0.01% | 1803 |
|
|
2016
Q3 | $2.45M | Buy |
53,234
+2,542
| +5% | +$107K | 0.01% | 1488 |
|
|
2016
Q2 | $1.73M | Buy |
+50,692
| New | +$1.58M | 0.01% | 1663 |
|
Other funds holding NGVT
SBH
RA
SCM
Guggenheim Capital's NGVT Position: Q3 2025 in Review
Guggenheim Capital sold out of Ingevity (NGVT) in Q3 2025, closing a stake of 5,903 shares — an estimated $254K sold.
Guggenheim Capital first reported a position in NGVT in Q2 2016 and held it in 36 quarters. The position peaked at $3.77M in Q1 2018. 298 funds tracked by Wall St. Rank hold NGVT as of Q3 2025.
- Guggenheim Capital reported no remaining Ingevity position as of Q3 2025 after selling out during the quarter.
- Guggenheim Capital sold 5,903 Ingevity shares in Q3 2025, an estimated $254K.
- Guggenheim Capital first reported a position in Ingevity in Q2 2016 and held it in 36 quarters.
- Guggenheim Capital's Ingevity position peaked at $3.77M in Q1 2018.
- 298 funds tracked by Wall St. Rank held Ingevity as of Q3 2025.
Based on Guggenheim Capital's 13F filing for Q3 2025, filed 13 Nov 2025.